Abstract

Background: Parkinson's disease affects many motor processes including speech. Besides drug treatment, deep brain stimulation (DBS) in the subthalamic nucleus (STN) and globus pallidus internus (GPi) has developed as an effective therapy.Goal: We present a neural model that simulates a syllable repetition task and evaluate its performance when varying the level of dopamine in the striatum, and the level of activity reduction in the STN or GPi.Method: The Neural Engineering Framework (NEF) is used to build a model of syllable sequencing through a cortico-basal ganglia-thalamus-cortex circuit. The model is able to simulate a failing substantia nigra pars compacta (SNc), as occurs in Parkinson's patients. We simulate syllable sequencing parameterized by (i) the tonic dopamine level in the striatum and (ii) average neural activity in STN or GPi.Results: With decreased dopamine levels, the model produces syllable sequencing errors in the form of skipping and swapping syllables, repeating the same syllable, breaking and restarting in the middle of a sequence, and cessation (“freezing”) of sequences. We also find that reducing (inhibiting) activity in either STN or GPi reduces the occurrence of syllable sequencing errors.Conclusion: The model predicts that inhibiting activity in STN or GPi can reduce syllable sequencing errors in Parkinson's patients. Since DBS also reduces syllable sequencing errors in Parkinson's patients, we therefore suggest that STN or GPi inhibition is one mechanism through which DBS reduces syllable sequencing errors in Parkinson's patients.

Highlights

  • Parkinson’s disease has a complex pathology and there are open questions regarding the genesis of the illness

  • The main mechanism seems to be the degradation of the substantia nigra in the basal ganglia (BG), which results in reduced levels of the neurotransmitter dopamine in the striatum (Goetz and Pal, 2014)

  • We focus on deep brain stimulation (DBS) in both the subthalamic nucleus (STN) and globus pallidus internus (GPi) because they are the most commonly targeted locations for Parkinson’s patients, and because there is no clear evidence that DBS is more effective in one vs. the other (Tan et al, 2016)

Read more

Summary

Introduction

Parkinson’s disease has a complex pathology and there are open questions regarding the genesis of the illness. The substantia nigra pars compacta (SNc) excites the striatum by through D1 dopamine receptors. The substantia nigra pars compacta (SNc) inhibits the striatum through D2 dopamine receptors. The activation of D1 receptors in the striatum (selection pathway) stimulates the striatum to inhibit the substantia nigra pars reticulata (SNr) and the globus pallidus internus (GPi). To ensure that only one action is completely disinhibited, the STN sends a broad excitatory signal to the SNr and GPi. the activation of D2 receptors results in disinhibition by inhibiting the striatum, which inhibits the globus pallidus pars externus (GPe). Goal: We present a neural model that simulates a syllable repetition task and evaluate its performance when varying the level of dopamine in the striatum, and the level of activity reduction in the STN or GPi

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call